panHER therapeutic vaccine (The Center of Molecular Immunology)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NamepanHER therapeutic vaccine (The Center of Molecular Immunology)

Drug Alias NameN/A

ClassificationVaccines > Application > Therapeutic vaccine

Mechanisms of ActionEpidermal growth factor receptor erbB1 modulatorsReceptor tyrosine-protein kinase erbB-3 modulatorsReceptor protein-tyrosine kinase erbB-2 modulators

TargetsEpidermal growth factor receptor erbB1Receptor protein-tyrosine kinase erbB-2Receptor tyrosine-protein kinase erbB-3

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCuba

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCenter Of Molecular Immunology

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCenter Of Molecular Immunology

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A